SUMITOMO PHARMA CO.,LTD. financial statements, including revenue, expenses, profit, and loss

The total revenue of DPM for the last quarter is 528.99 M EUR, and it's 8.58% higher compared to the previous quarter. The net income of Q3 23 is -320.83 M EUR.